Stability of input costs, specialty product launches to support performance of Indian pharma…
Revenues of ICRA’s sample set expected to grow by 6-8 per cent in FY2023 and FY2024; operating profit margins to stabilise at…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
mergers and acquisitions
M&As in bio/pharma industry high despite COVID-19: GlobalData
Down only 13 per cent compared with last year, with a total deal value of $228 billion compared with $262 billion in 2020, and…